|
The CCNY/MSKCC Partnership for Research, Training and Outreach
|
3U54CA137788-03S1
|
$200,000
|
$24,000
|
Ahles, Tim
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The CCNY/MSKCC Partnership for Research, Training and Outreach
|
5U54CA137788-03
|
$1,506,183
|
$180,742
|
Ahles, Tim
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Treatment of Osteoradionecrosis with Bone Marrow Stromal Cells
|
5K08CA120875-05
|
$138,381
|
$138,381
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S1
|
$100,000
|
$1,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S2
|
$143,893
|
$1,439
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S3
|
$100,000
|
$1,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-32
|
$4,161,905
|
$41,619
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Antigen Specific T Cell tolerance by Anti CD3 Antibodies
|
5R01CA132197-08
|
$379,132
|
$379,132
|
ANASETTI, CLAUDIO
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
2P01CA078378-11A2
|
$2,056,275
|
$514,069
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-18
|
$287,403
|
$43,110
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$644,596
|
$128,919
|
Anderson, Stephen
|
CCR (NCI)
|
|
THE THERAPY OF AML
|
5P01CA055164-18
|
$2,483,417
|
$894,030
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Mechanisms of GVHD
|
5P01CA142106-07
|
$1,916,255
|
$1,916,255
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$289,223
|
$28,922
|
Aplan, Peter
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$289,223
|
$289,223
|
Aplan, Peter
|
CCR (NCI)
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
2T32CA009515-26
|
$616,306
|
$616,306
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Adult Leukemia Research Center
|
5P01CA018029-35
|
$4,628,534
|
$4,628,534
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
|
ZIA SC 010282
|
$143,810
|
$28,762
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$503,334
|
$503,334
|
Arthur, Diane
|
CCR (NCI)
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
ZIA BC 010997
|
$99,147
|
$99,147
|
Avital, Itzhak
|
CCR (NCI)
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIA BC 011003
|
$198,294
|
$39,659
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$297,441
|
$297,441
|
Avital, Itzhak
|
CCR (NCI)
|
|
Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch
|
ZIA BC 011005
|
$198,294
|
$198,294
|
Avital, Itzhak
|
CCR (NCI)
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-05
|
$486,075
|
$486,075
|
BAKER, KEVIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-16
|
$3,080,284
|
$1,540,142
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
2P50CA083639-11
|
$2,231,452
|
$133,887
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
2P30CA042014-21
|
$1,483,602
|
$14,836
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-21S1
|
$99,413
|
$994
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Surgical Oncology Research Training
|
2T32CA106493-06
|
$106,583
|
$26,646
|
BEHRNS, KEVIN
|
UNIVERSITY OF FLORIDA
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
$929
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
$232,835
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-12
|
$534,606
|
$267,303
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-32
|
$218,479
|
$87,392
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
ZIA BC 010698
|
$183,397
|
$128,378
|
Bishop, Michael
|
CCR (NCI)
|
|
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$183,397
|
$183,397
|
Bishop, Michael
|
CCR (NCI)
|
|
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
|
ZIA SC 010365
|
$244,529
|
$24,453
|
Bishop, Michael
|
CCR (NCI)
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-04
|
$311,600
|
$102,828
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Hematopoietic Lineage-restricted Minor Histocompatibility Antigens as GVL Targets
|
5R01CA118880-04
|
$235,181
|
$235,181
|
BRICKNER, ANTHONY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA046934-23S1
|
$99,997
|
$3,000
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA046934-23S2
|
$99,946
|
$2,998
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
The Therapy of CML
|
2P01CA049639-20A2
|
$3,596,592
|
$467,557
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Novel Approaches to Stem Cell Transplantation
|
5P01CA047741-17
|
$1,843,346
|
$1,843,346
|
Chao, Nelson
|
DUKE UNIVERSITY
|
|
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia
|
7K08CA120544-05
|
$133,272
|
$33,318
|
CHIANG, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Mechanisms of Symptoms of Multiple Myeloma and Its Therapy
|
5P01CA124787-03
|
$2,183,628
|
$218,363
|
CLEELAND, CHARLES
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia
|
1R01CA141303-01A1
|
$303,780
|
$303,780
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Enhancing the efficacy of CD19-specific cord blood-derived T Cells
|
5R01CA120956-04
|
$292,600
|
$146,300
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
5R01CA124782-04
|
$292,600
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Total relevant funding to Organ Transplantation Research for this search: $77,288,304
|